27 Materials Science research jobs at Center for Biologics Evaluation and Research (CBER) in USA
-
through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 1 day ago
activities. Anticipated Appointment Start Date: June 1, 2024 This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 1 day ago
, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 1 day ago
its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 3 months ago
materials for traditional and global hemostasis assays. Res Pract Thromb Haemost. 2020 Dec 23;5(1):211-222. 4. Jackson JW, Surov SS, Liang Y, Parunov LA, Ovanesov MV. Effect of pH on thrombin activity
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 1 day ago
Date: February 1, 2024; start date is flexible This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 1 day ago
." medRxiv (2022): 2022-12. 3. Rodriguez Messan, Marisabel, et al. "Mathematical model of a personalized neoantigen cancer vaccine and the human immune system." PLoS Computational Biology 17.9 (2021): e1009318